(19)
(11) EP 4 213 831 A1

(12)

(43) Date of publication:
26.07.2023 Bulletin 2023/30

(21) Application number: 20780975.7

(22) Date of filing: 18.09.2020
(51) International Patent Classification (IPC): 
A61K 31/198(2006.01)
A61K 31/4406(2006.01)
A61P 31/14(2006.01)
 A61K 31/205(2006.01)
A61K 31/7084(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/198; A61K 31/205; A61K 31/4406; A61K 31/7084; A61P 31/14
 
C-Sets:
  1. A61K 31/198, A61K 2300/00;
  2. A61K 31/205, A61K 2300/00;
  3. A61K 31/4406, A61K 2300/00;
  4. A61K 31/7084, A61K 2300/00;
(86) International application number:
PCT/EP2020/076194
(87) International publication number:
WO 2022/058026 (24.03.2022 Gazette 2022/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: ScandiBio Therapeutics AB
121 36 Johanneshov (SE)

(72) Inventors:
  • MARDINOGLU, Adil
    412 60 Göteborg (SE)
  • BORÉN, Jan
    414 67 Göteborg (SE)
  • UHLÉN, Mathias
    181 90 Lidingö (SE)

(74) Representative: Kransell & Wennborg KB 
P.O. Box 27834
115 93 Stockholm
115 93 Stockholm (SE)

   


(54) SUPPLEMENT FOR TREATMENT OF CORONAVIRUS INFECTION